Replies to post #52872 on Therapeutic Solutions International Inc (TSOI)

[tractor4sale]

So who is overseeing the trials for the TSOI IND # 28685 if it’s NOT Biorasi? The University of Miami? It must have been press released to keep investors notified? TSOI was granted the “May Proceed Notification” back in the end of March! What’s happening on this front knowing it’s almost 5 months old now? Was this a misprint in the press release “the CURRENTLY ONGOING Double Blind Placebo Controlled Phase III”…

Therapeutic Solutions International announced today granting of Emergency IND # 28685 and a "May Proceed Notification" from the Food and Drug Administration (FDA) for the treatment of advanced COVID-19 ARDS outside of the currently ongoing Double Blind Placebo Controlled Phase III clinical trial for the same indication. The Company previously announced treatment of 15 "no option patients" under both "eIND" and "Right to Try" Law1


https://www.businesswire.com/news/home/20220328005440/en/Therapeutic-Solutions-International-Selects-Premier-Regenerative-Medicine-CRO-Biorasi-to-Initiate-and-Run-Phase-III-FDA-Registration-Clinical-Trial-for-JadiCell%E2%84%A2-Universal-Donor-Adult-Stem-Cell-Product

The Right to Try Act, or the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act, was signed into law May 30, 2018. This law is another way for patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments”…